natgillin/translations-raw huggingface dataset:
The body’s immune system thinks a transplanted organ is a foreign body and will try to reject it.
Imunski sistem prepozna presajeni organ kot tujek in ga poskuša zavrniti.
The bolus dose remains 0.75 mg/kg; or 0.5 mg/kg in patients who proceed to PCI after receiving bivalirudin pre-cath lab (UA/NSTEMI).
Bolusni odmerek ostane 0,75 mg/kg (ali 0,5 mg/kg pri bolnikih, ki so napoteni na PCI po prejemu bivalirudina v postopku priprave na kateterizacijo (UA/NSTEMI)).
the bone marrow,
kostnega mozga,
The booklets can be of 3 types or a single patient booklet that combines the information for each patient category:
brošure so lahko treh vrst ali pa v obliki ene same brošure za bolnike, ki kombinira informacije za vsak razred bolnikov:
The booster dose in clinical studies was given at 11- 12 months after a 2-dose primary series or at 12 months of age after a 3-dose primary series vaccination.
Obnovitveni odmerek je bil v kliničnih preskušanjih dan 11 ali 12 mesecev po osnovnem cepljenju z 2 odmerkoma, ali pri starosti 12 mesecev po osnovnem cepljenju s 3 odmerki.
The booster dose should be given at least 6 months after the last priming dose and preferably before 18 months of age.
Obnovitveni odmerek je treba dati vsaj 6 mesecev po zadnjem odmerku osnovnega cepljenja in po možnosti pred 18. mesecem starosti.
The booster dose should be given at least 6 months after the last priming dose and preferably between 11 and 13 months of age.
Obnovitveni odmerek je treba dati vsaj 6 mesecev po zadnjem odmerku osnovnega cepljenja in po možnosti med 11. in 13. mesecem starosti.
The Bother domain score is a composite of the following patient-reported items: concern about erection pain, erection appearance, and the impact of Peyronie’s disease on intercourse and on frequency of intercourse.
Rezultat Področja težav je sestavljen iz naslednjih postavk, o katerih poročajo bolniki: skrb zaradi bolečine ob erekciji, izgled erekcije in vpliv Peyroniejeve bolezni na spolni odnos in pogostnost spolnega odnosa.
The bottle adapter should not be removed.
Nastavka za steklenico ne smete odstraniti.
The bottle can be kept sealed with the flexible lid of the adapter.
Plastenka je lahko med shranjevanjem zaprta s pomičnim adapterjevim pokrovčkom.
The bottle cap (in the medicine pack)
zaporko za steklenico (v pakiranju),
The bottle contains 170 ml of solution.
Plastenka vsebuje 170 ml raztopine.
The bottle contains 250 ml of oral solution.
Steklenička vsebuje 250 ml peroralne raztopine.
The bottle contains a desiccant in a small cylinder shaped container.
Plastenka vsebuje majhen, cilindrično oblikovan vsebnik s sušilom.
The bottle contains desiccant canisters that should remain in the bottle.
V plastenkah je sušilno sredstvo, ki mora ostati v plastenki.
The bottle contains two sealed canisters containing silica gel to keep the capsules dry.
Vsebnik vsebuje dve enoti sušilnega sredstva, ki vsebujeta silikagel, ki ohranja kapsule suhe.
The bottle contains two sealed canisters containing silica gel to keep the tablets dry.
Vsebnik vsebuje dve enoti sušilnega sredstva, ki vsebujeta silikagel, ki ohranja tablete suhe.
The bottle may not be available in your country.
Pakiranje v plastenki ni nujno na voljo v vaši drţavi.
The bottle neck is filled with a low density polyethylene (LDPE) insert that accomodates the dosing pipette.
V vratu vsebnika je nameščen vložek iz polietilena nizke gostote (LDPE), v katerega se prilega odmerna kapalka.
The bottle pack contains canisters with a desiccant for keeping the tablets dry.
Steklenica vsebuje sušilni vložek, ki ohranja tablete suhe.
The bottle should be placed on a flat, horizontal surface, for example a table top, and only use it in a vertical position.
Stekleničko postavimo na ravno vodoravno površino, na primer na mizo, in jo uporabljamo izključno v navpičnem položaju.
The bottle should be placed on a flat, horizontal surface, for example a table top, and only use it in a vertical position..
Stekleničko postavimo na ravno vodoravno površino, na primer na mizo, in jo uporabljamo izključno v navpičnem položaju.
The bottle should not be removed from refrigerated conditions for more than 30 days.
Plastenka ne sme biti zunaj hladilnika več kot 30 dni.
The bottle should remain in an upright position when withdrawing the solution.
Steklenica naj bo medtem postavljena pokonci.
The bottles are closed with a butyl elastomer closure and sealed with an aluminium cap
Viale so zaprte z butil elastomernim zamaškom in zaščitene z aluminijasto zaporko.
The bottles are closed with a nitryle rubber stopper and sealed with a coded aluminium cap.
Stekleničke so zaprte z zamaški iz nitrilne gume in zaporkami iz aluminija s šifro.
The bottles are closed with a rubber stopper and an aluminium cap.
Steklenička in plastenka sta zaprti z gumijastim zamaškom in aluminijasto zaporko.
The bottles contain 30 or 90 film-coated tablets.
Plastenke vsebujejo 30 ali 90 filmsko obloženih tablet.
The bottles contain desiccant canisters that should remain in the container.
V plastenki je sušilno sredstvo, ki mora v njej tudi ostati.
The bottom of the chamber MUST be above the grey button.
Spodnji rob komore MORA biti nad sivim gumbom.
The box also contains 1 plastic measuring jug (52 ml), 1 plastic bottle adapter (to help get the drug into the dispenser) and 1 plastic oral dispenser (to give the correct amount of medicine via the mouth).
Škatla vsebuje tudi plastično merilno čašo (52 ml), plastični nastavek za steklenico (da lažje damo zdravilo v odmernik) in plastični peroralni odmernik (za natančno odmerjanje zdravila v usta).
The boxes containing Revlimid capsules also include a warning stating that lenalidomide is expected to be harmful to the unborn child.
Škatle, ki vsebujejo kapsule zdravila Revlimid, so opremljene z opozorilom, da je lenalidomid lahko za nerojene otroke škodljiv.
The boxes containing Thalidomide Celgene capsules will include a warning stating that thalidomide is harmful to the unborn child.
Škatle s kapsulami zdravila Thalidomide Celgene bodo vsebovale opozorilo, na katerem bo navedeno, da je talidomid škodljiv za nerojenega otroka.
The BRAFi-naïve patients (n=63) attained an 87% objective response rate, including a complete response in 16% of patients.
Bolniki, predhodno še nezdravljeni z BRAFi (n = 63), so dosegli 87-% objektivni delež odziva, vključno s popolnim odzivom pri 16 % bolnikov.
The brain contains so- called N-methyl-D-aspartate (NMDA)-receptors that are involved in transmitting nerve signals important in learning and memory.
V možganih so tako imenovani receptorji N-metil-D-aspartata (NMDA), ki sodelujejo v prenosu živčnih signalov, pomembnih za učenje in spomin.
The brain has a specific area that controls nausea and vomiting.
V možganih so posebna področja, ki nadzorujejo navzeo (siljenja na bruhanje) in bruhanje.
The breast cancers diagnosed in ever-users tend to be less advanced clinically than the cancers diagnosed in never-users.
Primeri raka dojke, odkriti pri ženskah, ki so kadar koli uporabljale KPK, so običajno v manj napredovalem kliničnem stadiju kot pri tistih, ki jih nikoli niso uporabljale.
The breath bag should be held upright and the bar-code label marked “00-minute-value” will be stuck on the breath bag.
Dihalno vrečko je treba držati pokonci in nanjo nalepiti črtno kodo z oznako "00-minutna vrednost" tako, da so črte v vodoravnem položaju.
The breath bags have to be sent in the original packaging, for analysis, to a qualified laboratory.
Vrečke z zrakom morate v originalni ovojnini poslati v usposobljen laboratorij, kjer jih bodo analizirali.
The breath from the bags will be introduced into the NDIR spectrometer using a variable gas pump.
Zrak boste spustili iz vrečk v spektrometer s pomočjo plinske črpalke.
The breath sample container should be held upright and the bar-code label marked “00-minute-value” will be stuck on the breath sample container.
Vsebnik za vzorec dihanja je treba držati pokonci in na vsebnik za vzorec dihanja nalepiti črtno kodo z oznako "00-minutna vrednost".
The breath sample containers (tube or breath bags) have to be sent for analysis, to a qualified laboratory.
Vsebnike z vzorcem izdihanega zraka (epruvete ali vrečke) morate poslati v usposobljen laboratorij, kjer jih bodo analizirali.
The breath samples, collected in 10 ml glass- or plastic sample tubes, are analysed by isotope ratio mass spectrometry (IRMS).
Vzorce izdihanega zraka, zbrane v 10 ml steklenih ali plastičnih epruvetah ali, analiziramo s spektrometrično metodo določanja razmerja mase izotopov (IRMS).
The breath samples, collected in 10 ml glass- or plastic sample tubes, are analysed by isotope ratio mass spectrometry (IRMS).
Vzorce izdihanega zraka, zbrane v 10 ml steklenih ali plastičnih epruvetah, analiziramo s spektrometrično metodo določanja razmerja mase izotopov (IRMS).
The breath samples, collected in 10 ml glass- or plastic sample tubes, are analysed by isotope ratio mass spectrometry (IRMS).
Vzorce izdihanega zraka, zbrane v 10-ml steklenih ali plastičnih epruvetah, analiziramo s spektrometrično metodo določanja razmerja mase izotopov (IRMS).
The breath samples, collected in 100 ml breath bags, are analysed by non-dispersive infrared spectrometry (NDIR).
Vzorce izdihanega zraka, zbrane v 100 ml vrečkah, analizirajte z nedisperzivno infrardečo spektrometrijo (NDIR).
The breath test concept is based upon the oral administration of 13C-labelled urea whose enzymatic hydrolysis is monitored by measuring 13CO2 in breath using non-dispersive infrared spectrometry.
Dihalni test je osnovan na zaužitju sečnine, označene s 13C, katere encimsko hidrolizo nadzorujemo z merjenjem 13CO2 v izdihanem zraku z nedisperzivno infrardečo spektrometrijo.
The breath test concept relies on the administration of a specifically 13C-labelled urea whose metabolite utilisation is monitored by measuring 13CO2 in the expired breath gas.
Koncept testa izdihanega zraka je zasnovan na uporabi s 13C specifično označene sečnine, katere porabo v presnovi nadzorujemo z merjenjem 13CO2 v izdihanem zraku.
The broad spectrum antimicrobial activity of gamithromycin includes Mannheimia haemolytica, Pasteurella multocida, Histophilus somni, Actinobacillus pleuropneumoniae and Haemophilus parasuis, the bacterial pathogens most commonly associated with BRD and SRD.
Širok spekter delovanja gamitromicina vključuje Manheimia haemolytica, Pasteurella multocida,Histophilus somni, Actinobacillus pleuropneumoniae in Haemophilus parasuis,bakterijske povzročitelje, ki so najpogosteje povezani z BRD in SRD.
The Broadline-treated cats were compared with cats treated with a spot-on medicine containing fipronil and (S)-methoprene.
Mačke, zdravljene z zdravilom Broadline, so primerjali z mačkami, zdravljenimi z zdravilom za kožni nanos, ki je vsebovalo fipronil in (S)-metopren.
The bronchodilatory effects with Incruse compared with placebo were evident after the first day of treatment in both studies and were maintained over the 12-week and 24-week treatment periods.
V obeh študijah so bili bronhodilatacijski učinki zdravila Incruse v primerjavi s placebom opazni že po prvem dnevu zdravljenja in so se ohranili med 12- in 24-tedenskim obdobjem zdravljenja.
The bulk drug substance manufacturing process also includes specific viral inactivation and removal steps.
Proces proizvodnje osnovne zdravilne učinkovine vključuje tudi specifične postopke inaktivacije in odstranitve virusov.
The bundled term burning sensation consists of the preferred terms burning sensation, skin burning sensation, and application site irritation, all of which referred specifically to burning at the application site.
Izraz pekoč občutek združuje izraze pekoč občutek, pekoč občutek na koži in draženje mesta aplikacije (ki se nanaša na pekoč občutek na mestu aplikacije).
The bupropion Cmax from naltrexone / bupropion (180 mg bupropion hydrochloride) was equivalent to the Cmax of bupropion PR (150 mg bupropion hydrochloride), indicating that the bupropion Cmax achieved with naltrexone / bupropion (360 mg bupropion hydrochloride /day) is comparable to that achieved with commercially available bupropion PR (300 mg bupropion hydrochloride /day) administered alone.
Vrednost Cmax za bupropion pri uporabi kombinacije naltrekson/bupropion (180 mg bupropionijevega klorida) je bila enakovredna vrednosti Cmax pri uporabi bupropiona s podaljšanim sproščanjem (150 mg bupropionijevega klorida), kar kaže, da je vrednost Cmax za bupropion, dosežena pri uporabi kombinacije naltrekson/bupropion (360 mg bupropionijevega klorida/dan), primerljiva z vrednostjo, doseženo pri samostojni uporabi komercialno dostopnih tablet bupropiona s podaljšanim sproščanjem (300 mg bupropionijevega klorida/dan).
The C1 inhibitor protein is required to control the ‘complement’ and ‘contact’ systems, collections of proteins in the blood that fight against infection and cause inflammation.
Beljakovina zaviralec C1 je potrebna za urejanje sistema komplementa in kontaktnega sistema, skupino beljakovin v krvi, ki se borijo proti okužbam in povzročajo vnetje.
The calculated in vitro Ki values for all cytochrome (CYP) isoforms tested (CYP1A2, CYP2A6, CYP2B6, CYP2C8, CYP2C9, CYP2C19, CYP2D6, CYP2E1, CYP3A4/5 and CYP4A9/11) indicated that sunitinib and its primary active metabolite are unlikely to induce metabolism, to any clinically relevant extent, of other actives substances that may be metabolised by these enzymes.
Na podlagi izračunanih in vitro vrednosti Ki za vse testirane izooblike citokromov – CYP (CYP1A2, CYP2A6, CYP2B6, CYP2C8, CYP2C9, CYP2C19, CYP2D6, CYP2E1, CYP3A4/5 in CYP4A9/11) je malo verjetno, da bi sunitinib in njegov primarni aktivni presnovek imela klinično pomemben vpliv na indukcijo presnove zdravilnih učinkovin, ki se presnavljajo s temi encimi.
The calculated quantity of asparaginase is dissolved further in 50 to 250 ml of sodium chloride 9 mg/ml (0.9 %) solution for injection.
Izračunano količino asparaginaze še nadalje raztopite v 50 do 250 ml raztopine natrijevega klorida 9 mg/ml (0,9 %) za injiciranje.
the calculated volume of Busulfan Fresenius Kabi must be removed from the vial.
izračunan volumen zdravila Busulfan Fresenius Kabi morate odstraniti iz viale,
The calculated volume of Elaprase should be withdrawn from the appropriate number of vials.
Vzemite izračunani volumen zdravila Elaprase iz ustreznega števila vial.
The calculated volume of olaratumab should be aseptically transferred into an empty intravenous infusion container.
Izračunano prostornino olaratumaba je treba aseptično prenesti v prazen vsebnik za intravensko infuzijo.
the calculation of the dose and of the volume of infusion
izračun odmerkov in prostornine infuzije,
the calculation of the infusion rate
izračun hitrosti infuzije,
The calculation of the required dosage of factor IX is based on the empirical finding that 1 International Unit (IU) factor IX per kg body weight raises the plasma factor IX activity by 1.1 % of normal activity.
Izračun potrebnega odmerka faktorja IX temelji na empiričnih izsledkih, da 1 mednarodna enota (i.e.) faktorja IX na kg telesne mase poviša aktivnost plazemskega faktorja IX za 1,1 % normalne aktivnosti.
The calculation of the required dose of BeneFIX can be based on the finding that one unit of factor IX activity per kg body weight is expected to increase the circulating level of factor IX, an average of
Potrebni odmerek zdravila BeneFIX lahko izračunamo na podlagi ugotovitve, da ena enota aktivnosti faktorja IX na kilogram telesne mase pričakovano zviša raven faktorja IX v krvi za povprečno
The calculation of the required dose of factor IX is based on the empirical finding that 1 International Unit (IU) factor IX per kg body weight raises the plasma factor IX activity by 0.7 IU/dL (range from 0.31 to 1.0 IU/dL) or 0.7% of normal activity in patients less than 12 years of age (further information see section 5.2).
Izračun potrebnega odmerka faktorja IX temelji na empiričnih izkušnjah, da 1 mednarodna enota (i.e.) faktorja IX na kg telesne mase pri bolnikih, mlajših od 12 let, zviša aktivnost faktorja IX v plazmi za 0,7 i.e./dl (razpon od 0,31 do 1,0 i.e./dl) ali 0,7 % normalne aktivnosti (za več informacij glejte poglavje 5.2).
The calculation of the required dose of factor IX is based on the empirical finding that 1 International Unit (IU) factor IX per kg body weight raises the plasma factor IX activity by 0.9 IU/dL (range from 0.5 to 1.4 IU/dL) or 0.9% of normal activity in patients 12 years and older (further information see section 5.2).
Izračun potrebnega odmerka faktorja IX temelji na empiričnih izkušnjah, da 1 mednarodna enota (i.e.) faktorja IX na kg telesne mase pri bolnikih, starih 12 let in več, zviša aktivnost faktorja IX v plazmi za 0,9 i.e./dl (razpon od 0,5 do 1,4 i.e./dl) ali 0,9 % normalne aktivnosti (za več informacij glejte poglavje 5.2).
The calculation of the required dose of factor IX is based on the empirical finding that 1 International Unit (IU) factor IX per kg body weight raises the plasma factor IX activity by 0.9 IU/dL (range from 0.5 to 1.4 IU/dL) or 0.9% of normal activity in patients 12 years and older (further information see section 5.2).
Izračun potrebnega odmerka faktorja IX temelji na empiričnih izkušnjah, da 1 mednarodna enota (i.e.) faktorja IX na kg telesne mase pri bolnikih, starih 12 let in več, zviša aktivnost faktorja IX v plazmi za 0,9 i.e./dl (razpon od 0,5 do 1,4 i.e./dl) ali 0,9 %normalne aktivnosti (za več informacij glejte poglavje 5.2).
The calorie target is the maximum number of calories you will eat each day.
Cilj vnosa kalorij je najvišje število kalorij, ki jih boste pojedli dnevno.
The canarypox viruses do not spread or multiply in the cat but they do produce proteins from the FeLV genes.
Poxvirusi kanarčkov se v mački ne širijo ali množijo, vendar pa tvorijo beljakovine iz genov virusa FeLV.
The cap is imprinted with ‘890’.
Na pokrovčku je odtisnjena oznaka »890«.
The cap is imprinted with ‘891’.
Na pokrovčku je odtisnjena oznaka »891«.
The cap is imprinted with ‘892’.
Na pokrovčku je odtisnjena oznaka »892«.
The cap is imprinted with ‘893’.
Na pokrovčku je odtisnjena oznaka »893«.
The cap is imprinted with ‘929’.
Na pokrovčku je odtisnjena oznaka »929«.
The cap is imprinted with ‘930’.
Na pokrovčku je odtisnjena oznaka »930«.
The cap must be turned anticlockwise, unscrewed completely and removed (fig.
Zaporko obračamo v obratni smeri urnega kazalca, jo do konca odvijemo in odstranimo (sl.
The cap opens by pushing and turning.
Zaporko odprete tako, da jo potisnete navzdol in zavrtite.
The cap should not be removed until you are ready to inject the medicine.
Pokrovčka ne smete sneti, dokler niste pripravljeni za injiciranje zdravila.
The CAPS trials with Ilaris included a total of 80 paediatric patients with an age range from 2 to 17 years (approximately half of them treated on an mg/kg basis).
Preskušanja zdravljenja periodičnih sindromov, povezanih s kriopirinom (CAPS), z zdravilom Ilaris so vključevala skupno 80 pediatričnih bolnikov v starosti od 2 do 17 let (približno polovica teh bolnikov je prejemala odmerke zdravila na osnovi mg/kg telesne mase).
The caps, alcohol pad, cotton ball or gauze pad, blister, and packaging may be put in your household waste.
V gospodinjske odpadke lahko zavržete pokrovčke, alkoholni zloženec, blazinico iz vate ali zloženec
The capsule body is caramel opaque, printed with ‘250’ axially in black ink.
Telo kapsule je karamelne barve s črnim napisom “250”v smeri osi kapsule.
The capsule cap is light blue opaque printed ‘M’ axially in black ink.
Glava kapsule je svetlo modra s črnim napisom “M” v smeri osi kapsule.
The capsule has a turquoise cap and turquoise body bearing the imprint of “ROCHE XENICAL 120”.
Ovoj kapsule in pokrovček sta turkizne barve z napisom ROCHE XENICAL 120.
The capsule is an orange cap/white body hard capsule of 19.4 mm, printed with black ink imprinted with “10 mg” on body and “A733” on cap.
Kapsula je trda kapsula z oranžnim pokrovčkom/oranžnim telesom, velika 19,4 mm, s črnima oznakama „10 mg“ na telesu in „A733“ na pokrovčku.
The capsule is axially printed with MYLAN over PB100 in black ink on cap and body.
Kapsula ima na telesu in pokrovčku kapsule s črnilom vzdolžno odtisnjeno oznako MYLAN preko PB100.
The capsule is axially printed with MYLAN over PB150 in black ink on cap and body.
Kapsula ima na telesu in pokrovčku s črnim črnilom vzdolžno odtisnjeno oznako MYLAN preko PB100.
The capsule is axially printed with MYLAN over PB200 in black ink on cap and body.
Kapsula ima na telesu in pokrovčku kapsule s črnilom vzdolžno odtisnjeno oznako MYLAN preko PB200.
The capsule is axially printed with MYLAN over PB225 in black ink on cap and body.
Kapsula ima na telesu in pokrovčku kapsule s črnilom vzdolžno odtisnjeno oznako MYLAN preko PB225.
The capsule is axially printed with MYLAN over PB25 in black ink on cap and body.
Kapsula ima na telesu in pokrovčku kapsule s črnilom vzdolžno odtisnjeno oznako MYLAN preko PB25.
The capsule is axially printed with MYLAN over PB25 in black ink on cap and body.
Kapsula ima na telesu in pokrovčku kapsule s črnim črnilom vzdolžno odtisnjeno oznako MYLAN preko PB25.
The capsule is axially printed with MYLAN over PB300 in black ink on cap and body.
Kapsula ima na telesu in pokrovčku kapsule s črnilom vzdolžno odtisnjeno oznako MYLAN preko PB300.
The capsule is axially printed with MYLAN over PB50 in black ink on cap and body.
Kapsula ima na telesu in pokrovčku kapsule s črnilom vzdolžno odtisnjeno oznako MYLAN preko PB50.
The capsule is axially printed with MYLAN over PB75 in black ink on cap and body.
Kapsula ima na telesu in pokrovčku kapsule s črnilom vzdolžno odtisnjeno oznako MYLAN preko PB75.
The capsule is now pierced and the contents can be inhaled.
Kapsula je tako prebodena in lahko vdihnete njeno vsebino.
The capsule may be stuck in the capsule chamber.
Morda se je kapsula zataknila v vdolbini.
The capsule may be taken with or without food
Kapsulo lahko vzamete skupaj s hrano ali brez nje.
The capsule or its contents should not be crushed, divided, dissolved, sucked or chewed as the enteric- coating of the microtablets prevents irritant effects on the gut.
Kapsule ali njene vsebine se ne sme drobiti, deliti, topiti, sesati ali žvečiti, saj enterična obloga mikrotablet preprečuje draženje črevesja.
The capsule shell and printing ink contain gelatine, shellac, ammonium hydroxide, simethicone, propylene glycol, indigocarmin (E132) and titanium dioxide (E171).
Ovojnica kapsule in tiskarsko črnilo vsebujeta želatino, šelak, amonijev hidroksid, simetikon, propilenglikol, indigotin (E132) in titanov dioksid (E171).
The capsule shell consists of gelatin, sorbitol special-glycerine blend (glycerin, sorbitol, sorbitol anhydrides (1,4-sorbitan), mannitol and water), titanium dioxide (E171) and printing ink (SDA 35A alcohol (ethanol & ethyl acetate), propylene glycol (E1520), iron oxide black (E172), polyvinyl acetate phthalate, purified water, isopropyl alcohol, macrogol 400, ammonium hydroxide 28%)
Ovojnica kapsule je iz želatine, zmesi sorbitola in posebnega glicerola (glicerol, sorbitol, sorbitol anhidridi (1,4-sorbitan), manitol in voda), titanovega dioksida (E171) in črnila (alkohol SDA 35A (etanol & etilacetat), propilenglikol (E1520), črni železov oksid (E172), polivinilacetat ftalat, prečiščena voda, izopropilalkohol, makrogol 400, amonijev hidroksid 28 %).
The capsule shell consists of gelatine, iron oxide black, red and yellow (E172), indigocarmine (E132), titanium dioxide (E171), and the printing ink contains titanium dioxide (E171), shellac, soya lecithin, polydimethylsiloxane.
Ovojnica kapsule vsebuje želatino, črni, rumeni in rdeči železov oksid (E172), indigotin (E132), titanov dioksid (E171) in barvilo za tisk, ki vsebuje titanov dioksid (E171), šelak, sojin lecitin, polidimetilsiloksan.
The capsule shell contains carrageenan, potassium chloride, titanium dioxide, indigo carmine, sunset yellow (E110) and hypromellose.
Ovojnica kapsule vsebuje karagenan, kalijev klorid, titanov dioksid, indigotin, sončno rumeno FCF (E110) in hipromelozo.
The capsule shell contains gelatin and titanium dioxide (E171).
Ovojnica kapsule vsebuje želatino in titanov dioksid (E171).